ASX:4DXHealthcare Services
4DMedical (ASX:4DX) Wins TGA Approval, But Is The Growth Story Already Priced In
4DMedical (ASX:4DX) is drawing fresh attention after securing Therapeutic Goods Administration approval for its CT:VQ lung imaging software, clearing the way for commercial deployment across Australian healthcare providers using existing CT infrastructure.
See our latest analysis for 4DMedical.
The TGA approval comes after a period of mixed share price momentum for 4DMedical, with a 1 month share price return of 8.42% contrasted by a 90 day share price decline of 24.65%. Over 1 year, the...